As antibody specificity for isolation of pHLA-E and MS instrumentation sensitivity continue to improve, there is considerable potential for high-throughput discovery and validation of HLA-E viral epitopes and tumor antigens. The gene discussed is HLA-E; the disease is neoplasm.